Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Maguire

Showing results (561-570 of 656) with videos related to

Pageof 66
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 22, 2013
Development of inducible leucine-rich repeat kinase 2 (LRRK2) cell lines for therapeutics development in Parkinson's diseaseLiang Huang, Mika Shimoji, Juan Wang, et al.
International Journal of Clinical Practice|November 21, 2020
Increasing access to erectile dysfunction treatment via pharmacies to improve healthcare provider visits and quality of life: Results from a prospective real-world observational study in the United KingdomLauren J Lee, Terence A Maguire, Martine C Maculaitis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2012
ADAM-17: a novel therapeutic target for triple negative breast cancerP M McGowan, M Mullooly, F Caiazza, et al.
Frontiers in Human Neuroscience|July 4, 2024
Psychedelics in developmental stuttering to modulate brain functioning: a new therapeutic perspective?Giuseppe Pasculli, Pierpaolo Busan, Eric S Jackson, et al.
Biological Psychiatry|August 22, 2001
Methods for developmental studies of fear conditioning circuitryD S Pine, A Fyer, J Grun, et al.
Analytical Chemistry|February 22, 2013
Directed molecular evolution reveals Gaussia luciferase variants with enhanced light output stabilityM Hannah Degeling, M Sarah S Bovenberg, Grant K Lewandrowski, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 12, 2012
Microglial activation and antioxidant responses induced by the Parkinson's disease protein α-synucleinDawn Béraud, Hannah A Hathaway, Jordan Trecki, et al.
The Journal of Clinical Investigation|May 1, 2024
BAP1 is required prenatally for differentiation and maintenance of postnatal murine enteric nervous systemSabine Schneider, Jessica B Anderson, Rebecca P Bradley, et al.
Brain Research|January 2, 2007
Effects of ex vivo transduction of mesencephalic reaggregates with bcl-2 on grafted dopamine neuron survivalCaryl E Sortwell, William J Bowers, Scott E Counts, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 21, 2008
Preventing growth of brain tumors by creating a zone of resistanceCasey A Maguire, Dimphna H Meijer, Stanley G LeRoy, et al.
Pageof 66

Showing results (561-570 of 656) with videos related to

Sort By:
Pageof 66
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 22, 2013
Development of inducible leucine-rich repeat kinase 2 (LRRK2) cell lines for therapeutics development in Parkinson's diseaseLiang Huang, Mika Shimoji, Juan Wang, et al.
International Journal of Clinical Practice|November 21, 2020
Increasing access to erectile dysfunction treatment via pharmacies to improve healthcare provider visits and quality of life: Results from a prospective real-world observational study in the United KingdomLauren J Lee, Terence A Maguire, Martine C Maculaitis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2012
ADAM-17: a novel therapeutic target for triple negative breast cancerP M McGowan, M Mullooly, F Caiazza, et al.
Frontiers in Human Neuroscience|July 4, 2024
Psychedelics in developmental stuttering to modulate brain functioning: a new therapeutic perspective?Giuseppe Pasculli, Pierpaolo Busan, Eric S Jackson, et al.
Biological Psychiatry|August 22, 2001
Methods for developmental studies of fear conditioning circuitryD S Pine, A Fyer, J Grun, et al.
Analytical Chemistry|February 22, 2013
Directed molecular evolution reveals Gaussia luciferase variants with enhanced light output stabilityM Hannah Degeling, M Sarah S Bovenberg, Grant K Lewandrowski, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 12, 2012
Microglial activation and antioxidant responses induced by the Parkinson's disease protein α-synucleinDawn Béraud, Hannah A Hathaway, Jordan Trecki, et al.
The Journal of Clinical Investigation|May 1, 2024
BAP1 is required prenatally for differentiation and maintenance of postnatal murine enteric nervous systemSabine Schneider, Jessica B Anderson, Rebecca P Bradley, et al.
Brain Research|January 2, 2007
Effects of ex vivo transduction of mesencephalic reaggregates with bcl-2 on grafted dopamine neuron survivalCaryl E Sortwell, William J Bowers, Scott E Counts, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 21, 2008
Preventing growth of brain tumors by creating a zone of resistanceCasey A Maguire, Dimphna H Meijer, Stanley G LeRoy, et al.
Pageof 66